Small Pharma to Host Virtual Roundtable Event with Key Opinion Leaders in Psychiatry Post published:March 7, 2023 Post category:Press Release
Reunion Neuroscience to Participate in the Oppenheimer Annual Healthcare Conference Post published:March 7, 2023 Post category:Press Release
Small Pharma Announces Further Positive Data from SPL026 Phase IIa Trial in Major Depressive Disorder Strengthening Topline Efficacy Results Post published:March 7, 2023 Post category:Press Release
Numinus Wellness Inc. Executives to Present on Panel at Upcoming South by Southwest Conference Post published:March 7, 2023 Post category:Press Release
atai Life Sciences Announces Key Clinical Pipeline and Corporate Updates Post published:March 6, 2023 Post category:Press Release
Mindset Pharma and PharmAla Complete First Sale of Pharmaceutical Grade Psilocybin Into Growing Australian Market via Sales Partnership Post published:March 6, 2023 Post category:Press Release
COMPASS Pathways to participate in upcoming Cowen 43rd Annual Health Care Conference, Oppenheimer 33rd Annual Healthcare Conference, and Loop Capital Investor Conference Post published:March 2, 2023 Post category:Press Release
GH Research Reports Full Year 2022 Financial Results and Provides Business Updates Post published:March 2, 2023 Post category:Press Release
Algernon NeuroScience Appoints Global TBI Expert and Former NFL Neurological Player Care Safety Director Dr. David Brody to Advisory Board Post published:March 2, 2023 Post category:Press Release